A year has passed since Stevenage Bioscience Catalyst (SBC), the UK’s first open innovation (OI) bioscience campus, opened for business. It celebrates its first birthday with occupancy levels on target, many milestones achieved and a vibrant biosciences hub being established. The year ahead promises to be just as exciting.

Highlights of the year at SBC included welcoming tenants big and small, the success of its inaugural Open Innovation Summit, launch of an Experts Panel, news of an innovative tie-up with Cambridge University, and a funding collaboration with Kurma Life Sciences Partners. SBC is pleased to have hosted many events and networking meetings for a range of organisations, and is building strong links with the local community.

Reflecting on the previous year, and looking ahead, CEO Martino Picardo said, ''I'm delighted that Stevenage Bioscience Catalyst's first year of operation has been such a success, as we've worked to bring the academic, pharma, bioscience and investor communities closer together. I'd like to thank our stakeholders for their input and ongoing support, as well as the SBC team and our advisers. Our second year is expected to be just as busy and fruitful, especially around the Convergent Medical Technologies conference we are planning for May.'